News

Emulsifiers alter gut bacteria in mice, set the stage for IBD and metabolic syndrome


 

FROM NATURE

References

The emulsifiers found in processed foods can alter the composition of gut microbiota and trigger intestinal inflammation that, in turn, may promote the development of inflammatory bowel disease and metabolic syndrome, Dr. Benoit Chassaing, PhD, of Georgia State University Institute for Biomedical Sciences, and his colleagues report Feb. 25 in Nature.

This photo shows bacteria that are present deeper in the mucus layer that lines the intestine and closer to the epithelium than they should be. Dr. Benoit Chassaing

This photo shows bacteria that are present deeper in the mucus layer that lines the intestine and closer to the epithelium than they should be.

The research team fed mice polysorbate 80 and carboxymethylcellulose, two commonly used emulsifiers, at doses replicating those found in processed foods. Emulsifier consumption changed the composition of the gut microbiota in the mice, resulting in a proinflammatory state. The bacteria were able to digest and infiltrate the intestine’s mucosal layer and the altered bacterial species expressed more flagellin and lipopolysaccharide, which can activate proinflammatory gene expression by the immune system.

The bacterial changes triggered chronic colitis in mice genetically prone to the disorder. In mice with normal immune systems, low-grade intestinal inflammation resulted, and metabolic syndrome was noted.

Transplanting the microbiota from mice fed emulsifiers to germ-free mice also transferred some parameters of low-grade inflammation and metabolic syndrome, indicating a central role for the microbiota in mediating the adverse effect of emulsifiers.

Recommended Reading

IBD specialty medical home relies on psychiatrist, insurer to succeed
MDedge Internal Medicine
NASH on the rise as a cause of liver transplants
MDedge Internal Medicine
Smoking linked to many ‘new’ causes of death
MDedge Internal Medicine
FDA allows marketing of vaginally inserted device for fecal incontinence
MDedge Internal Medicine
HPV-16 E6 seropositivity common before anal cancer develops
MDedge Internal Medicine
Remission before conception: goal for IBD patients desiring pregnancy
MDedge Internal Medicine
Difficult-to-clean ERCP duodenoscopes linked to serious infections
MDedge Internal Medicine
Two regimens achieve high response in HCV/HIV coinfection
MDedge Internal Medicine
Death rates rising for liver cancer, falling for colorectal cancer
MDedge Internal Medicine
Tumor location portends CRC survival
MDedge Internal Medicine